investor

Upcoming PDUFA Dates Could Be Major Catalysts For These 3 Biotech Stocks

In the biotech realm, the author of today’s article notes that “PDUFA (Prescription Drug User Fee Act) dates – the deadline of the FDA’s review of new drugs – determine whether a treatment is fit for purpose or not and a yay or nay can act as a major catalyst to send shares either soaring or crashing.” As such, he… 

4 Stocks To Play This “Hot Technology Silo”

Of the four stocks highlighted in today’s article, the author declares them “outstanding ideas for aggressive growth investors looking to add this hot technology silo.” The silo in question? Cybersecurity and analytics, which, in a new research report, Goldman Sachs is very positive on. For four top new trends in cybersecurity and analytics that Goldman noted in its report, as… 

These Marijuana Stocks Are Analysts’ Favorites

While the best way to ride the marijuana legalization wave may be through exchange-traded funds, for those interested in specific stock ideas, which marijuana stocks are analysts’ favorites? Today’s article sifts through the holdings of the six largest marijuana ETFs to identify them. For a list of these marijuana stocks and their respective upside potential, CLICK HERE.

“Stockpicker’s Paradise”: 2 “Strong Buy” Penny Stocks With Upside Potential Over 200%

“We stick to our view that 2021 will be a stockpicker’s paradise with big money-making opportunities if you are willing to go against the grain,” asserts one small/mid-cap stock strategist cited in today’s article, which proceeds to highlight two penny stocks that boast “Strong Buy” consensus ratings and upside potential over 200%. For these two penny stocks, CLICK HERE.

“The Best Proxy For The Trends That Can Help You Make Money”

What’s the best proxy for the trends that can help you make money? The answer may be the 50-day moving average, which the author of today’s article advises “is in the goldilocks zone of not being too short or too long.” Using the example of a potentially game-changing stock from the green energy sector, he outlines how traders can use… 

“The Biggest Contrarian Bet You Can Make Today”

“To me, this is the biggest contrarian bet you can make today. If you’ve got the guts to make the trade, it could lead to massive upside from here,” says the author of today’s article in regards to the investment opportunity he outlines – one that involves an investment that, being cheap, hated and in the start of an uptrend,… 

A Diamond In The Rough & 2 Other Top Biotech Stock Picks For 2021

One of the strongest biotechs out there, a diamond in the rough, and a high-risk, high-reward play make up the three biotech stocks identified by the author of today’s article as top picks for 2021 for investors looking for even better biotech returns than those offered by broad biotech ETFs such as the SPDR S&P Biotech ETF. For a look… 

With Many Psychedelic Stocks Posting Triple-Digit Returns, The “Shroom Boom” May Just Be Beginning

While biotech stocks have been hot over the last year, today’s article notes that another group of stocks have been trading like biotech companies of late: psychedelic stocks. In fact, a slew of psychedelic stocks have posted triple-digit returns over the last year – and with the impending release of studies examining the use of psychedelics to treat mental health… 

2021 Is Sure To Bring New Problems Requiring More Tech – And These 3 Stocks Could Benefit

While many are hopeful that 2021 will bring better times than 2020, there’s much we don’t know about what this new year has in store. One thing we do know, points out the author of today’s article, is that “there will be new problems needing more tech, and tech investors are ever-ready to pounce when that time comes.” As such,… 

These Biotechs Are Awaiting FDA Decisions In January

While the most important decisions made by the FDA in December were undoubtedly the Emergency Use Authorizations for two COVID-19 vaccines, the month also saw a number of firsts on the regulatory front, including the authorization of the first test allowing for at-home collection of patient samples to detect both COVID-19 and influenza A and B. Now, today’s article takes…